Cationic hydrophobic peptides with antimicrobial activity

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3585-3590

  Stark, Margareta ^a   Liu, Li Ping ^a   Deber, Charles M ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CYSTEINE; ISOLEUCINE; LEUCINE; METHIONINE; PHENYLALANINE; TRYPTOPHAN; VALINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID BILAYER; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CHEMISTRY, PHYSICAL; CIRCULAR DICHROISM; ERYTHROCYTES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PEPTIDES; RABBITS;

EID: 0036840580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3585-3590.2002     Document Type: Article

References (37)

1. Amsterdam, D. 1996. Susceptibility testing of antimicrobials in liquid media, p. 52-111. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
2. Bechinger, B. 1999. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim. Biophys. Acta 1462:157-183.
3. Blondelle, S. E., E. Pérez-Payá, and R. A. Houghten. 1996. Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrob. Agents Chemother. 40:1067-1071.
4. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
5. Bonomo, R. A. 2000. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin. Infect. Dis. 31:1414-1422.
6. Brock, T. D. 1974. Biology of microorganisms, 2nd ed. Prentice-Hall, Inc., Englewood Cliffs, N.J.
7. Deber, C. M., C. Wang, L. P. Liu, A. S. Prior, S. Agrawal, B. L. Muskat, and A. J. Caticchia. 2001. TM Finder: a prediction program for transmembrane protein segments using a combination of hydrophobicity and nonpolar phase helicity scales. Protein Sci. 10:212-219.
8. Hancock, R. E. 1997. Peptide antibiotics. Lancet 349:418-422.
9. Hancock, R. E. 1999. Host defence (cationic) peptides: what is their future clinical potential? Drugs 57:469-473.
10. Hancock, R. E., T. Falla, and M. Brown. 1995. Cationic bactericidal peptides. Adv. Microb. Physiol. 37:135-175.
11. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
12. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
13. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
14. Hong, J., Z. Oren, and Y. Shai. 1999. Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Biochemistry 38:16963-16973.
15. Hwang, P. M., and H. J. Vogel. 1998. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol. 76:235-246.
16. Kuroiwa, T., M. Sakaguchi, K. Mihara, and T. Omura. 1991. Systematic analysis of stop-transfer sequence for microsomal membrane. J. Biol. Chem. 266:9251-9255.
17. La Rocca, P., Y. Shai, and M. S. Sansom. 1999. Peptide-bilayer interactions: simulations of dermaseptin B, an antimicrobial peptide. Biophys. Chem. 76:145-159.
18. Liu, L. P., and C. M. Deber. 1997. Anionic phospholipids modulate peptide insertion into membranes. Biochemistry 36:5476-5482.
19. Liu, L. P., and C. M. Deber. 1998. Guidelines for membrane protein engineering derived from de novo designed model peptides. Biopolymers 47:41-62.
20. Liu, L. P., S. C. Li, N. K. Goto, and C. M. Deber. 1996. Threshold hydrophobicity dictates helical conformations of peptides in membrane environments. Biopolymers 39:465-470.
21. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1-10.
22. Melnyk, R. A., A. W. Partridge, and C. M. Deber. 2001. Retention of native-like oligomerization states in transmembrane segment peptides: application to the Escherichia coli aspartate receptor. Biochemistry 40:11106-11113.
23. Oren, Z., J. Hong, and Y. Shai. 1997. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272:14643-14649.
24. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic alphahelical antimicrobial peptides. Biopolymers 47:451-463.
25. Richmond, M. H., D. C. Clark, and S. Wotton. 1976. Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains. Antimicrob. Agents Chemother. 10:215-218.
26. Robinson, C. 2000. The twin-arginine translocation system: a novel means of transporting folded proteins in chloroplasts and bacteria. Biol. Chem. 381:89-93.
27. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
28. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
29. Tossi, A., C. Tarantino, and D. Romeo. 1997. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur. J. Biochem. 250:549-558.
30. Turner, J. D., and G. Rouser. 1970. Precise quantitative determination of human blood lipids by thin-layer and triethylaminoethylcellulose column chromatography. I. Erythrocyte lipids. Anal. Biochem. 38:423-436.
31. van't Hof, W., E. C. Veerman, E. J. Helmerhorst, and A. V. Amerongen. 2001. Antimicrobial peptides: properties and applicability. Biol. Chem. 382:597-619.
32. Verkleij, A. J., R. F. Zwaal, B. Roelofsen, P. Comfurius, D. Kastelijn, and L. L. van Deenen. 1973. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta 323:178-193.
33. Williams, J. D. 2001. Antibiotic resistance in hospital pathogens-acquisition or spread? Int. J. Antimicrob. Agents 18:295-298.
34. Wong, A. H., R. P. Wenzel, and M. B. Edmond. 2000. Epidemiology of bacteriuria caused by vancomycin-resistant enterococci - a retrospective study. Am. J. Infect. Control 28:277-281.
35. Wu, M., and R. E. Hancock. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.
36. Ziihner, H., and H.-P. Fiedler. 1995. The need for new antibiotics: possible ways forward, p. 67-85. In P. A. Hunter, G. K. Darby, and N. J. Russell (ed.), Fifty years of antimicrobials: past perspectives and future trends. Cambridge University Press, Cambridge, England.
37. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.